Compare $ATYR vs $JSPR | Chartloom

Compare

$ATYR vs $JSPR

aTyr Pharma Inc · Jasper Therapeutics Inc

ATYR

aTyr Pharma Inc

JSPR

Jasper Therapeutics Inc

Compare $ATYR vs $JSPR

Comparing aTyr Pharma Inc and Jasper Therapeutics Inc

ATYRaTyr Pharma Inc

JSPRJasper Therapeutics Inc

ATYRaTyr Pharma Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.1%

YTD performance

-67.6%

52W performance

-75.4%

FCF yield

-227.1%

JSPRJasper Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.0%

52W performance

-76.2%

FCF yield

-318.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATYR

JSPR

Detailed metrics comparison

ATYR

aTyr Pharma Inc

JSPR

Jasper Therapeutics Inc

Market Cap

ATYR$24M

JSPR$19M

Enterprise Value

ATYR$9M

JSPR$12M

Price

ATYR$0.25

JSPR$0.57

P/E Ratio

ATYRN/A

JSPRN/A

P/S Ratio

ATYR127.05x

JSPR0.00x

EV/Sales

ATYR44.92x

JSPR0.00x

EV/EBITDA

ATYR0.00x

JSPR0.00x

P/B Ratio

ATYR0.58x

JSPR13.31x

P/FCF Ratio

ATYRN/A

JSPRN/A

EV/FCF

ATYR-0.16x

JSPR-0.19x

PEG Ratio

ATYRN/A

JSPRN/A

Forward P/E (NTM)

ATYRN/A

JSPRN/A

Forward P/S (NTM)

ATYRN/A

JSPRN/A

Revenue (TTM)

ATYR$190K

JSPR$0

Revenue Growth (YoY)

ATYR-19.1%

JSPRN/A

Forward Rev Growth

ATYR2461.0%

JSPR-81.1%

Gross Margin (TTM)

ATYR0.0%

JSPR0.0%

Operating Margin (TTM)

ATYR0.0%

JSPR0.0%

EBITDA Margin (TTM)

ATYR-21689.5%

JSPR0.0%

Net Margin (TTM)

ATYR-20898.4%

JSPR0.0%

FCF Margin (TTM)

ATYR-28852.1%

JSPRN/A

Net Income (TTM)

ATYR$-40M

JSPR$-32M

FCF (TTM)

ATYR$-55M

JSPR$-60M

EPS (TTM)

ATYR$0.00

JSPR-$1.11

ROE (TTM)

ATYR-9962.0%

JSPR-61887.0%

ROA (TTM)

ATYR-7441.0%

JSPR-10067.0%

ROIC (TTM)

ATYR-9817.0%

JSPR-61887.0%

Cash

ATYR$16M

JSPR$7M

Debt

ATYR$554K

JSPR$0

Net Cash/Debt

ATYR$16M

JSPR$7M

Current Ratio (TTM)

ATYR5.12x

JSPR1.48x

Quick Ratio (TTM)

ATYR5.08x

JSPR1.02x

Debt/Equity (TTM)

ATYR0.01x

JSPR0.00x

Debt/Assets (TTM)

ATYR0.0%

JSPR0.0%

Interest Coverage (TTM)

ATYRN/A

JSPRN/A

Net Debt/EBITDA (TTM)

ATYR0.00x

JSPR0.00x

Beta

ATYR0.99

JSPR3.37

52W Performance

ATYR-75.4%

JSPR-76.2%

YTD Performance

ATYR-67.6%

JSPR-69.0%

% from 52W High

ATYR-78.0%

JSPR-78.8%

% from 52W Low

ATYR0.1%

JSPR81.0%

Asset Turnover (TTM)

ATYR0.00x

JSPR0.00x

FCF Yield (TTM)

ATYR-227.1%

JSPR-318.0%

Earnings Yield (TTM)

ATYR-164.5%

JSPR-167.5%

Dividend Yield (TTM)

ATYRN/A

JSPRN/A

Rule of 40

ATYR-28,871.3

JSPR0.0

EV/GP/RG

ATYRN/A

JSPRN/A

Ticker research

View ATYR research View JSPR research

Metric	ATYR aTyr Pharma Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$24M	$19M
Enterprise Value	$9M	$12M
Price	$0.25	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	127.05x	0.00x
EV/Sales	44.92x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.58x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.16x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$190K	$0
Revenue Growth (YoY)	-19.1%	N/A
Forward Rev Growth	2461.0%	-81.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-21689.5%	0.0%
Net Margin (TTM)	-20898.4%	0.0%
FCF Margin (TTM)	-28852.1%	N/A
Net Income (TTM)	$-40M	$-32M
FCF (TTM)	$-55M	$-60M
EPS (TTM)	$0.00	-$1.11
ROE (TTM)	-9962.0%	-61887.0%
ROA (TTM)	-7441.0%	-10067.0%
ROIC (TTM)	-9817.0%	-61887.0%
Financial Health
Cash	$16M	$7M
Debt	$554K	$0
Net Cash/Debt	$16M	$7M
Current Ratio (TTM)	5.12x	1.48x
Quick Ratio (TTM)	5.08x	1.02x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	3.37
52W Performance	-75.4%	-76.2%
YTD Performance	-67.6%	-69.0%
% from 52W High	-78.0%	-78.8%
% from 52W Low	0.1%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-227.1%	-318.0%
Earnings Yield (TTM)	-164.5%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-28,871.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATYR research	View JSPR research

Valuation

P/S Ratio

JSPR

0.00x

ATYR

127.05x

EV/FCF

JSPR

-0.19x

ATYR

-0.16x

Growth & revenue

Revenue Growth TTM

ATYR

-19.1%

Forward Revenue Growth

ATYR

2461.0%

JSPR

-81.1%

Profitability & performance

Gross Margin

ATYR

0.0%

JSPR

0.0%

ROE

ATYR

-9962.0%

JSPR

-61887.0%

FCF Yield %

ATYR

-227.1%

JSPR

-318.0%

52-Week Performance

ATYR

-75.4%

JSPR

-76.2%

Detailed metrics comparison

ATYR

aTyr Pharma Inc

JSPR

Jasper Therapeutics Inc

Market Cap

ATYR$24M

JSPR$19M

Enterprise Value

ATYR$9M

JSPR$12M

Price

ATYR$0.25

JSPR$0.57

P/E Ratio

ATYRN/A

JSPRN/A

P/S Ratio

ATYR127.05x

JSPR0.00x

EV/Sales

ATYR44.92x

JSPR0.00x

EV/EBITDA

ATYR0.00x

JSPR0.00x

P/B Ratio

ATYR0.58x

JSPR13.31x

P/FCF Ratio

ATYRN/A

JSPRN/A

EV/FCF

ATYR-0.16x

JSPR-0.19x

PEG Ratio

ATYRN/A

JSPRN/A

Forward P/E (NTM)

ATYRN/A

JSPRN/A

Forward P/S (NTM)

ATYRN/A

JSPRN/A

Revenue (TTM)

ATYR$190K

JSPR$0

Revenue Growth (YoY)

ATYR-19.1%

JSPRN/A

Forward Rev Growth

ATYR2461.0%

JSPR-81.1%

Gross Margin (TTM)

ATYR0.0%

JSPR0.0%

Operating Margin (TTM)

ATYR0.0%

JSPR0.0%

EBITDA Margin (TTM)

ATYR-21689.5%

JSPR0.0%

Net Margin (TTM)

ATYR-20898.4%

JSPR0.0%

FCF Margin (TTM)

ATYR-28852.1%

JSPRN/A

Net Income (TTM)

ATYR$-40M

JSPR$-32M

FCF (TTM)

ATYR$-55M

JSPR$-60M

EPS (TTM)

ATYR$0.00

JSPR-$1.11

ROE (TTM)

ATYR-9962.0%

JSPR-61887.0%

ROA (TTM)

ATYR-7441.0%

JSPR-10067.0%

ROIC (TTM)

ATYR-9817.0%

JSPR-61887.0%

Cash

ATYR$16M

JSPR$7M

Debt

ATYR$554K

JSPR$0

Net Cash/Debt

ATYR$16M

JSPR$7M

Current Ratio (TTM)

ATYR5.12x

JSPR1.48x

Quick Ratio (TTM)

ATYR5.08x

JSPR1.02x

Debt/Equity (TTM)

ATYR0.01x

JSPR0.00x

Debt/Assets (TTM)

ATYR0.0%

JSPR0.0%

Interest Coverage (TTM)

ATYRN/A

JSPRN/A

Net Debt/EBITDA (TTM)

ATYR0.00x

JSPR0.00x

Beta

ATYR0.99

JSPR3.37

52W Performance

ATYR-75.4%

JSPR-76.2%

YTD Performance

ATYR-67.6%

JSPR-69.0%

% from 52W High

ATYR-78.0%

JSPR-78.8%

% from 52W Low

ATYR0.1%

JSPR81.0%

Asset Turnover (TTM)

ATYR0.00x

JSPR0.00x

FCF Yield (TTM)

ATYR-227.1%

JSPR-318.0%

Earnings Yield (TTM)

ATYR-164.5%

JSPR-167.5%

Dividend Yield (TTM)

ATYRN/A

JSPRN/A

Rule of 40

ATYR-28,871.3

JSPR0.0

EV/GP/RG

ATYRN/A

JSPRN/A

Ticker research

View ATYR research View JSPR research

Metric	ATYR aTyr Pharma Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$24M	$19M
Enterprise Value	$9M	$12M
Price	$0.25	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	127.05x	0.00x
EV/Sales	44.92x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.58x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.16x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$190K	$0
Revenue Growth (YoY)	-19.1%	N/A
Forward Rev Growth	2461.0%	-81.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-21689.5%	0.0%
Net Margin (TTM)	-20898.4%	0.0%
FCF Margin (TTM)	-28852.1%	N/A
Net Income (TTM)	$-40M	$-32M
FCF (TTM)	$-55M	$-60M
EPS (TTM)	$0.00	-$1.11
ROE (TTM)	-9962.0%	-61887.0%
ROA (TTM)	-7441.0%	-10067.0%
ROIC (TTM)	-9817.0%	-61887.0%
Financial Health
Cash	$16M	$7M
Debt	$554K	$0
Net Cash/Debt	$16M	$7M
Current Ratio (TTM)	5.12x	1.48x
Quick Ratio (TTM)	5.08x	1.02x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	3.37
52W Performance	-75.4%	-76.2%
YTD Performance	-67.6%	-69.0%
% from 52W High	-78.0%	-78.8%
% from 52W Low	0.1%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-227.1%	-318.0%
Earnings Yield (TTM)	-164.5%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-28,871.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATYR research	View JSPR research